Hardy TS Kagimoto founded his first biotech company after working at Kyushu University Hospital in 2005.He then founded HEALIOS K.K. in February 2011 with the goal of making the promise of regenerative medicine a reality. In February 2012, he became the CEO of Healios and in June 2015, he led its listing on the Tokyo Stock Exchange Mothers index. He is working on the creation of a new regenerative and cellular medicine industry to realize his driving objective: delivering healing and hope to patients suffering from intractable diseases.

What I expect of LINK-J

I hope that LINK-J will be able to build an ecosystem to develop Japanese Biotechnology all over the world.

Message to LINK-J Special Members

The success of the ecosystem depends on our cooperation.
Let's enjoy building the communities